BioCentury
ARTICLE | Company News

Rigel, Albany Molecular in optimization deal

May 31, 2001 7:00 AM UTC

AMRI will provide RIGL with medicinal chemistry services for RIGL's mast cell program in asthma and allergy. RIGL is developing small molecule inhibitors of secreted inflammatory factors. RIGL will pr...